title: Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
abstract: Prescription sales of testosterone have risen considerably over the last decade and are likely to continue to grow as further preparations become available. Testosterone promotes existing prostate cancer; however, concern does exist as to whether or not testosterone therapy induces prostate cancer. The aim of this article is to review the evidence for such a link.
authors.affiliation: The Prostate Centre, Wimpole Street, London, UK. duncangould@hotmail.com
authors.forename: D C
authors.initials: DC
authors.lastname: Gould
authors.forename: R S
authors.initials: RS
authors.lastname: Kirby
mesh_terms: D000818:Animals; D020249:Hormone Replacement Therapy; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011467:Prostate / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000139:chemically induced*; D012307:Risk Factors; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D013739:Testosterone